CDMO strategy

CDMO strategy

PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities

PCI Pharma Services, a world-leading integrated global contract development and manufacturing organisation (CDMO) focused on innovative biologic and small molecule therapies, has announced a...
Read more
- Advertisement -spot_img
- Advertisement -
- Advertisement -
DDF Summit ad
- Advertisement -
EPO Summit ad
- Advertisement -
ILMAC ad
- Advertisement -

Latest posts

Load more

Drug Discovery & Development (DDD) is dedicated to advancing scientific innovations into active medical solutions. Its aim is to accelerate breakthroughs in medicine, addressing human disease and improving global health outcomes.

Menu

© Web design by Social Media Services 2026. All rights reserved.